Multiple studies have reported inhibition of cell proliferation and/or cell cycle progression in breast cancer cell lines upon pharmacological PDI-inhibition or PDIA3 silencing (121, 122, 128, 133). This evidence concerns the gene P4HB and breast carcinoma.